SAM
EW icon

Sentinel Asset Management’s Edwards Lifesciences EW Stock Holding History

Sentinel Asset Management’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-10,200
Closed -$242K – 250
2015
Q2 		$242K Sell
10,200
-13,800
-58% -$311K 0.01% 247
2015
Q1 		$570K Buy
+24,000
New +$538K 0.01% 239

Other funds holding EW

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Winslow Capital Management
Winslow Capital Management Minneapolis, Minnesota $29.1B AUM 43.86% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
VOYA Investment Management
VOYA Investment Management Atlanta, Georgia $116B AUM 61.47% 1-Year Est. Return

Sentinel Asset Management's EW Position: Q3 2015 in Review

Sentinel Asset Management sold out of Edwards Lifesciences (EW) in Q3 2015, closing a stake of 10,200 shares — an estimated $242K sold.

Sentinel Asset Management first reported a position in EW in Q1 2015 and held it in 2 quarters. The position peaked at $570K in Q1 2015. 569 funds tracked by Wall St. Rank hold EW as of Q3 2015.

  • Sentinel Asset Management reported no remaining Edwards Lifesciences position as of Q3 2015 after selling out during the quarter.
  • Sentinel Asset Management sold 10,200 Edwards Lifesciences shares in Q3 2015, an estimated $242K.
  • Sentinel Asset Management first reported a position in Edwards Lifesciences in Q1 2015 and held it in 2 quarters.
  • Sentinel Asset Management's Edwards Lifesciences position peaked at $570K in Q1 2015.
  • 569 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q3 2015.

Based on Sentinel Asset Management's 13F filing for Q3 2015, filed 13 Nov 2015.